New FDA commissioner Scott Gottlieb is reshaping the drug industry with an ambitious agenda. Investors should watch him closely.

While General Motors is retreating to its lucrative but shrinking home market, Renault is pinning extravagant hopes on emerging-markets growth.

The market seems to be undervaluing the Japanese tech conglomerate’s collection of stakes in tech companies.

European regulators are turning up the heat on bad loans and Italy’s banks will feel it most.

The way the stock market reacts to Friday’s jobs report may say more about the stock market than it does about jobs.

The second season of the streaming service’s “Stranger Things” launches later this month—conveniently about a week after many of the company’s U.S.